157 related articles for article (PubMed ID: 31648498)
1. [Clinical analysis of 121 cases of urothelial carcinoma accompanied with multiple primary carcinoma].
Gu YC; Ye JF; Cao BS; Wang MP; Ma LL; Ma LW
Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):760-764. PubMed ID: 31648498
[No Abstract] [Full Text] [Related]
2. Molecular subtype classification of urothelial carcinoma in Lynch syndrome.
Therkildsen C; Eriksson P; Höglund M; Jönsson M; Sjödahl G; Nilbert M; Liedberg F
Mol Oncol; 2018 Aug; 12(8):1286-1295. PubMed ID: 29791078
[TBL] [Abstract][Full Text] [Related]
3. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M;
BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159
[TBL] [Abstract][Full Text] [Related]
4. Loss of DAB2IP expression in human urothelial carcinoma is associated with poorer recurrence-free survival.
Jou YC; Tsai YS; Chen SY; Hsieh HY; Tsai HT; Tzai TS
Virchows Arch; 2016 Jun; 468(6):733-40. PubMed ID: 27003158
[TBL] [Abstract][Full Text] [Related]
5. [Transitional carcinomas of the urinary tract: synchronous and metachronous lesions].
Arrizabalaga M; Navarro J; Mora M; Castro M; Extramiana J; Mañas A; Diez J; Paniagua P
Actas Urol Esp; 1994 Sep; 18(8):782-96. PubMed ID: 7998507
[TBL] [Abstract][Full Text] [Related]
6. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Pignot G; Colin P; Zerbib M; Audenet F; Soulié M; Hurel S; Delage F; Irani J; Descazeaud A; Droupy S; Rozet F; Phé V; Ruffion A; Long JA; Crouzet S; Houlgatte A; Bigot P; Guy L; Faïs PO; Rouprêt M;
Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
[TBL] [Abstract][Full Text] [Related]
7. Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy.
Bertz S; Wach S; Taubert H; Merten R; Krause FS; Schick S; Ott OJ; Weigert E; Dworak O; Rödel C; Fietkau R; Wullich B; Keck B; Hartmann A
Virchows Arch; 2016 Sep; 469(3):339-44. PubMed ID: 27392930
[TBL] [Abstract][Full Text] [Related]
8. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF
World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210
[TBL] [Abstract][Full Text] [Related]
9. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
[TBL] [Abstract][Full Text] [Related]
10. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M
Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma.
Kuroda K; Asakuma J; Asano T; Horiguchi A; Isono M; Tsujita Y; Sato A; Seguchi K; Ito K; Asano T
Jpn J Clin Oncol; 2015 Jan; 45(1):103-10. PubMed ID: 25324479
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of kidney transplant tourism and risk factors for de novo urothelial carcinoma.
Tsai HL; Chang JW; Wu TH; King KL; Yang LY; Chan YJ; Yang AH; Chang FP; Pan CC; Yang WC; Loong CC
Transplantation; 2014 Jul; 98(1):79-87. PubMed ID: 24879380
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
Nguyen D; Taheri D; Springer S; Cowan M; Guner G; Mendoza Rodriguez MA; Wang Y; Kinde I; VandenBussche CJ; Olson MT; Ricardo BF; Cunha I; Fujita K; Ertoy D; Kinzler KW; Bivalacqua TJ; Papadopoulos N; Vogelstein B; Netto GJ
Virchows Arch; 2016 Oct; 469(4):427-34. PubMed ID: 27520411
[TBL] [Abstract][Full Text] [Related]
14. [Clinical value of fluorescence in situ hybridization positive of exfoliated urothelial cells in urothelial carcinoma].
Liu JY; Peng X; Ning XH; Li T; Peng SH; Wang JY; Liu SJ; Ding Y; Cai L; Gong K
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):585-589. PubMed ID: 28816270
[TBL] [Abstract][Full Text] [Related]
15. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease.
Chen CY; Liao YM; Tsai WM; Kuo HC
J Formos Med Assoc; 2007 Dec; 106(12):992-8. PubMed ID: 18194904
[TBL] [Abstract][Full Text] [Related]
16. Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer Studies.
Moschini M; Shariat SF; Rouprêt M; De Santis M; Bellmunt J; Sternberg CN; Tombal B; Collette L
J Urol; 2018 May; 199(5):1149-1157. PubMed ID: 29158104
[TBL] [Abstract][Full Text] [Related]
17. Identical clonal origin of synchronous and metachronous low-grade, noninvasive papillary transitional cell carcinomas of the urinary tract.
Li M; Cannizzaro LA
Hum Pathol; 1999 Oct; 30(10):1197-200. PubMed ID: 10534167
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of urothelial carcinoma.
Miyazaki J; Nishiyama H
Int J Urol; 2017 Oct; 24(10):730-734. PubMed ID: 28543959
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
